Norphin Injection 2ml
MRP: ₹0.00
Packaging
1 x 1 INJECTION
Composition
Buprenorphine 0.3mg/1ml
Company
Unichem
MRP: ₹0.00
Packaging
1 x 1 INJECTION
Composition
Buprenorphine 0.3mg/1ml
Company
Unichem
| Medicine | Company | Price | You Save | |
|---|---|---|---|---|
| No substitutes available. | ||||
Sedation, nausea, dizziness, vertigo, hypotension, miosis, headache, hypoventilation, resp or CNS depression; tachycardia, bradycardia, urinary retention, coma, vomiting, drowsiness, sweating, confusion, dry mouth, diaphoresis, withdrawal syndrome.
Plasma-buprenorphine concentrations may be affected when co-administered with drugs that induce or inhibit cytochrome P450 isoenzyme CYP3A4. Enhanced depressant effects with other CNS depressants e.g. alcohol, anaesthetics, anxiolytics, hypnotics, TCAs and antipsychotics. Potentially Fatal: Diazepam may produce resp and cardiac collapse.
Acute alcoholism; convulsive disorders; head injuries; increased intracranial pressure; comatose patients; resp depression and obstructive airway disease; patients on established opioid agonists.
Buprenorphine exerts its analgesic effect by binding to the mu-opioid receptors in the CNS. It has a longer duration of analgesic action than morphine. Its partial agonist activity gives it a low level of physical dependence. Buprenorphine and morphine show similar dose-related resp depressant effect. Absorption: Rapidly absorbed through the muscles (IM), buccal mucosa (sublingual); peak plasma concentrations after 90 minutes (sublingual). Distribution: Enters breast milk. Protein-binding: 96%. Metabolism: Minimal 1st-pass effect; converted to N-dealkylbuprenorphine and conjugated metabolites. There is enterohepatic recirculation. Excretion: Via faeces (mainly unchanged), via urine (small amounts as unchanged); 1.2-7.2 hr (elimination half-life).
Hepatic or renal disease; pregnancy, lactation; hypothyroidism; adrenocortical insufficiency; asthma; prostatic hyperplasia; shock; hypotension; inflammatory or obstructive bowel disorders; myasthaenia gravis; infants/neonates. Reduce dose in elderly and debilitated patients. May precipitate withdrawal symptoms in narcotic addicts.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Calligraff Capsule 10s | CAP | ₹99.00 |
| Adhair 2% Lotion | LOTION | ₹247.00 |
| Adhair 5% Solution 60ml | LOTION | ₹578.00 |
| Allerfex 180mg Tablet 10s | TAB | ₹128.50 |
| Allerfex M Tablet 10s | TAB | ₹112.70 |
| Almecol OD Capsule 10s | CAP | ₹105.20 |
| Almecol OD Capsule 10s | CAP | ₹105.20 |
| Ampoxin Dry Syrup | SYRUP | ₹22.40 |
| Ampoxin KidTab | CAP | ₹24.00 |
| Ampoxin Plus Capsule 10s | CAP | ₹0.00 |
| Ampoxin-1gm Inj. | INJECTION | ₹27.25 |
| Ampoxin-250 Cap | CAP | ₹35.40 |
| Ampoxin-250mg Inj. | INJECTION | ₹18.55 |
| Ampoxin-500 Cap | CAP | ₹61.00 |
| Ampoxin-500mg Inj. | INJECTION | ₹21.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist